2 FTSE 100 dividend stocks I’d buy and hold for the next 10 years

These two FTSE 100 (INDEXFTSE:UKX) shares could offer income investing potential in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the FTSE 100 having a dividend yield of around 4.3%, there are numerous income investing opportunities available to investors at the present time.

In the long run, many of those companies could offer improving financial performance that boosts their share prices. And, since their valuations continue to be low in many cases, now could be the right time to buy them.

Here are two prime examples of dividend stocks that could outperform the FTSE 100 in the next decade.

GSK

Healthcare companies such as GSK (LSE: GSK) could experience strong earnings growth over the next 10 years. Demand for a range of healthcare services and drugs is likely to increase as the world’s population grows in size and also continues to see its average age rise.

GSK’s recent updates have shown that it is making progress in implementing its current strategy. This includes a joint venture within its consumer health brands portfolio, as well as M&A activity within its pharma sector. These changes could catalyse its financial performance and increase its appeal among investors.

The company’s dividend has been frozen on a per share basis over recent years. This has been a positive move in terms of the overall financial health of the business, since it now means that dividends are covered 1.5 times by net profit. There may now be scope for shareholder payouts to increase at a brisk pace, while a dividend yield of 4.5% is competitive compared to other FTSE 100 stocks.

With GSK trading on a price-to-earnings (P/E) ratio of 15, it seems to offer good value for money given its long-term prospects. As such, now could be the right time to buy a slice of it.

Berkeley

Another FTSE 100 share that could be worth buying and holding for the next decade is Berkeley (LSE: BKG). The prime housebuilder, which focuses on the London market, has experienced a challenging set of trading conditions in recent years.

Planning difficulties and lower demand following the EU referendum have contributed to weaker levels of profitability. However, the company is placed favourably to benefit from an improvement in the London housing market, where it has a large market share compared to many of its sector peers.

Encouragingly, Berkeley has a strong balance sheet and an ability to focus on long-term projects. This strategy is performing relatively well according to its recent updates, with the company on track to meet its medium-term financial guidance.

With the stock forecast to pay a dividend yield of 3.5% in the current year and 4.1% next year, it continues to offer sound income opportunities. And, with the London property market having the potential to gain ground as political risk subsides, now could be the right time to buy a slice of the stock and hold it for the long run.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of Berkeley Group Holdings and GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black man sat in front of laptop while wearing headphones
Investing Articles

Investing just £10 a day in UK stocks could bag me a passive income stream of £267 a week!

This Fool explains how investing in UK stocks rather than buying a couple of takeaway coffees a day could help…

Read more »

Investing Articles

A cheap stock to consider buying as the FTSE 100 hits all-time highs

Roland Head explains why the FTSE 100 probably isn’t expensive and highlights a cheap dividend share to consider buying today.

Read more »

Investing Articles

If I were retiring tomorrow, I’d snap up these 3 passive income stocks!

Our writer was recently asked which passive income stocks she’d be happy to buy if she were to retire tomorrow.…

Read more »

Investing Articles

As the FTSE 100 hits an all-time high, are the days of cheap shares coming to an end?

The signs suggest that confidence and optimism are finally getting the FTSE 100 back on track, as the index hits…

Read more »

Investing Articles

Which FTSE 100 stocks could benefit after the UK’s premier index reaches all-time highs?

As the FTSE 100 hit all-time highs yesterday, our writer details which stocks could be primed to climb upwards.

Read more »

Investing Articles

Down massively in 2024 so far, is there worse to come for Tesla stock?

Tesla stock has been been stuck in reverse gear. Will the latest earnings announcement see the share price continue to…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Dividend Shares

These 2 dividend stocks are getting way too cheap

Jon Smith looks at different financial metrics to prove that some dividend stocks are undervalued at the moment and could…

Read more »

Investing Articles

Is the JD Sports share price set to explode?

Christopher Ruane considers why the JD Sports share price has done little over the past five years, even though sales…

Read more »